Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

著者: Paul Moayyedi, John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Leanne Dyal, Olga Shestakovska, Darryl P. Leong, Sonia S. Anand, Stefan Störk, Kelley R. Branch, Deepak L. Bhatt, Peter Verhamme, Martin O’Donnell, Aldo P. Maggioni, Eva Lonn, Leopoldo Soares Piegas, Georg Ertl, Mátyás Keltai, Nancy Cook Bruns, Eva Muehlhofer, Gilles R. Dagenais, Jae‐Hyung Kim, Masatsugu Hori, Philippe Gabríel Steg, Robert G. Hart, Rafael Díaz, Marco Alings, Petr Widimský, Álvaro Avezum, Jeffrey L. Probstfield, Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf - Gastroenterology 2019 被引用: 477